Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing

Esophageal squamous cell carcinoma (ESCC) is a deadly disease with a low 5-year survival rate. Anti-epidermal growth factor receptor (EGFR) therapy has been widely used in the treatment of malignancies, and chemotherapy regimens that include nimotuzumab have been confirmed to have satisfactory effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Dantong, Yan, Weihua, Zhu, Hua, Liu, Qiaoling, Hou, Helei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658551/
https://www.ncbi.nlm.nih.gov/pubmed/33194681
http://dx.doi.org/10.3389/fonc.2020.574523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658551/
https://www.ncbi.nlm.nih.gov/pubmed/33194681
http://dx.doi.org/10.3389/fonc.2020.574523

Ejemplares similares